新型荧光光纤免疫磁珠流动分析系统研究（Ⅰ）

将荧光免疫分析技术、光纤传感技术、流动注射技术和免疫磁珠分离技术联用,建立了一种新型荧光光纤免疫磁珠流动分析系统,并采用荧光素异硫氰酸酯（FITC）对系统性能进行考察,结果表明该分析系统设计合理,性能可靠,在临床、环保等领域有广泛的应用前景。     

贵金属Au冷却过程中结构及能量变化的分子动力学计算机模拟

通过分子动力学方法,研究了不同冷速下贵金属Au在温度2000～300K的冷却过程中微观结构的变化特点。结果发现,冷却速度对Au的微观结构产生重要影响。采用偶关联函数和键对分析技术对原子局域团簇结构进行分析,并考察了冷却过程中原子势能随温度的变化,比较了Au的微观结构转变与能量变化的对应关系,从能量转化的角度对冷却过程中Au的结构变化进行了说明。     

Growth of Carbon Nanotubes over Ni Nano-particles Prepared in Situ by Reduction of La2NiO4 Oxides

Carbonnanotubes(CNTs),theallotropeofcarbon,haveattractedmuchspeculationfortheirextraordinarypropertiesandpotentialapplicationssincetheywerediscoveredl.NowthesynthesisofCNTsisoneofthechallengingissuesinthenewcarbonmaterialsfield.ThecatalyticproductionofCNTsissimplerandmorereproduciblethanothermethods2*3.Inthepresentwork,weobtainedgroWthofCNTsbycatalyticdisproportionationofCOoverNinano-particlespreparedbyreducingLa2NiO..Therareearthoxidescanpreventtransitionmetalfromagglomefatingandpromo…     

长白山白眉蝮蛇蛇毒精氨酸酯酶1的研究Ⅱ.酶学性质和荧光光谱研究(续Ⅰ)

测得了长白山白眉蝮蛇毒精氨酸酯酶 1的最适反应的pH范围为 7.0～ 8.0 ,且与酶反应底物对甲苯磺酰-L -精氨酸甲酯 (TAME)的反应无明显的最适应反应温度 .荧光光谱的研究结果表明 :该酶的酪氨酸残基的荧光被色氨酸残基的荧光所掩盖 ;同步荧光光谱结果表明 :当发射波长与激发波长差Δλ分别为 2 0nm和 75nm时 ,精氨酸酯酶 1的荧光光谱分别由酪氨酸 (Tyr)和色氨酸 (Trp)残基所贡献 ,且处于亲水性环境中 ;精氨酸酯酶 1的荧光发射强度受溶液酸度变化的影响 .I- ,Acr和NBS对精氨酸酯酶 1的荧光淬灭结果表明这种酶中含有多个色氨酸残基 ,且处于不同的微环境中。     

三苯胺-吡啶衍生物的三光子吸收及光限幅特性

合成了3个三苯胺-吡啶衍生物4-乙烯基吡啶-4'-(N,N-二苯胺基)苯(PPAB)、三[4-(4-吡啶乙烯基)苯]胺(TPPA)和4-(对-甲基-乙烯基吡啶碘盐)-4'-(N,N-二苯胺基)苯(PBPI),研究了它们的单光子荧光和三光子荧光性质.在1310nm飞秒激光激发下,化合物PPAB,PBPI and TPPA在二氯甲烷溶液中发出很强的三光子上转换荧光,荧光峰分别位于648,625,696nm.用飞秒Ti:Sapphire激光器非线性透过率法测得3个化合物在1310nm三光子吸收截面分别为1.91×10-79,3.46×10-79,3.64×10-79cm6·s2,它们具有很强的三光子吸收和光限幅效应.     

水助甲酰胺-H2O2氧化乙烯制环氧乙烷反应机理的理论研究

采用MP2方法研究了甲酰胺-H2O2氧化乙烯制取环氧乙烷的反应机理.优化得到了反应物、过渡态、中间体及产物的几何构型并计算了反应势垒.研究结果表明:没有水参与时,反应需要通过四元环过渡态完成,反应势垒很高,在常温下难以进行;有水参与时,在水分子的协助下,反应可以通过六元环过渡态完成,反应势垒较低,常温下反应容易进行.     

热处理对高硫化氢合成气一步法制甲硫醇K2MoO4-NiO/SiO2催化剂结构及性能的影响

 在不同焙烧温度和焙烧气氛下对共浸渍法制备的 K2MoO4-NiO/SiO2 催化剂进行热处理, 并采用 X 射线衍射、热重-差示扫描量热、氢气程序升温还原、拉曼光谱和电子自旋共振波谱等手段对催化剂进行了表征, 同时考察了催化剂催化高硫化氢合成气一步法制甲硫醇的性能. 结果表明, 由于催化剂中所含柠檬酸氧化放热, 空气中焙烧的催化剂发生严重烧结. 随着焙烧温度的升高, 八面体配位的 Mo(Oh) 逐渐向四面体配位的 Mo(Td) 转变, 导致催化剂的还原能力降低, 配位不饱和 Mo (CO 吸附位) 减少, 因而 CO 转化率降低. 甲硫醇的生成与 Mo–S–K 相密切相关, 而 MoS2 晶相表面主要生成烃类. 与氮气中焙烧的催化剂相比, 空气中焙烧的催化剂表面的 MoS2 相较多, 而 Mo–S–K 相较少, 因此具有更高的烃类选择性和更低的甲硫醇选择性.     

LC–MS/MS method for the simultaneous determination of ethyl gallate and its major metabolite in rat plasma

A simple, rapid and sensitive liquid chromatography–tandem mass spectroscopy (LC–MS/MS) method was developed and validated for the determination of ethyl gallate, a pharmacologically active constituent isolated from Lagerstroemia speciosa (Linn.) Pers. This method was used to examine the pharmacokinetics of ethyl gallate and its major metabolite gallic acid in rat plasma using propyl gallate as an internal standard. After precipitation of the plasma proteins with acetonitrile, the analytes were separated on a Zorbax SB‐C₁₈ column (3.5 μm, 2.1 × 50 mm) with an isocratic mobile phase consisted of methanol–acetonitrile–10 mM ammonium acetate (10 : 25 : 65, v/v/v) containing 0.1% formic acid at a flow rate of 0.25 mL/min. The Agilent G6410A triple quadrupole LC/MS system was operated under the multiple‐reaction monitoring mode using the electrospray ionization technique in negative mode. The lower limits of quantification of gallic acid and ethyl gallate of the method were 0.5 and 1.0 ng/mL. The intra‐day and inter‐day accuracy and precision of the assay were less than 8.0%. This method has been applied successfully to a pharmacokinetic study involving the intragastric administration of ethyl gallate to rats. Copyright © 2009 John Wiley & Sons, Ltd.     

Determination of asperosaponin VI in rat plasma by HPLC‐ESI‐MS and its application to preliminary pharmacokinetic studies

Asperosaponin VI (also named akebia saponin D) is a typical bioactive triterpenoid saponin isolated from the rhizome of Dipsacus asper Wall (Dipsacaceae). In this work, a sensitive high‐performance liquid chromatography–electrospray ionization–mass spectrometry (HPLC‐ESI‐MS) assay has been established for determination of asperosaponin VI in rat plasma. With losartan as the internal standard (IS), plasma samples were prepared by protein precipitation with methanol. Chromatographic separation was performed on a C₁₈ column with a mobile phase of 10 mm ammonium acetate buffer containing 0.05% formic acid–methanol (32 : 68, v/v). The analysis was performed on an ESI in the selected ion monitoring mode using target ions at m/z 951.4 for asperosaponin VI and m/z 423.2 for the IS. The calibration curve was linear over the range 3–1000 ng/mL and the lower limit of quantification was 3.0 ng/mL. The intra‐ and inter‐assay variability values were less than 9.5 and 7.8%, respectively. The accuracies determined at the concentrations of 3.0, 100.0, 300.0 and 1000 ng/mL for asperosaponin VI were within ±15.0%. The validated method was successfully applied to a pharmacokinetic study in rats after oral administration of asperosaponin VI. Copyright © 2009 John Wiley & Sons, Ltd.